Showing results (1481-1490 of 2,110) with videos related to
Sort By:
Pageof 211
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2014
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trialJoshua P Loh, Pieter R Stella, Giuseppe Sangiorgi, et al.Msphere|March 5, 2025
The role of l-serine and l-threonine in the energy metabolism and nutritional stress response of <i>Trypanosoma cruzi</i>Mayke Bezerra Alencar, Richard Marcel Bruno Moreira Girard, Marcell Crispim, et al.Herz|June 26, 2003
[4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002]Benny Levenson, Alexander Albrecht, Stefan Göhring, et al.Journal of the American College of Cardiology|October 24, 2002
Age-dependent changes of cardiac neuronal noradrenaline reuptake transporter (uptake1) in the human heartKirsten Leineweber, Thekla Wangemann, Christine Giessler, et al.Advanced Functional Materials|March 12, 2021
siRNA nanoparticle suppresses drug-resistant gene and prolongs survival in an orthotopic glioblastoma xenograft mouse modelKui Wang, Forrest M Kievit, Peter A Chiarelli, et al.Langmuir : the ACS Journal of Surfaces and Colloids|August 10, 2018
Efficient Propulsion and Hovering of Bubble-Driven Hollow Micromotors underneath an Air-Liquid InterfaceLei-Lei Wang, Li Chen, Jing Zhang, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|December 8, 1998
Effects of the ovarian cycle on sympathetic neural outflow during static exerciseS M Ettinger, D H Silber, K S Gray, et al.Biochemical and Biophysical Research Communications|August 15, 1994
Isolation of a heregulin-like growth factor secreted by estrogen receptor-negative MDA-MB-231 human breast cancer cells that stimulates estrogen receptor-positive cellsW Küng, F David, H Langen, et al.Journal of the American College of Cardiology|March 6, 2007
Arterial reactivity in lower extremities is progressively reduced as cardiovascular risk factors increase: comparison with upper extremities using magnetic resonance imagingHarry A Silber, Joao A C Lima, David A Bluemke, et al.Clinical and Vaccine Immunology : CVI|March 6, 2009
Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or olderSantosh C Sutradhar, William W B Wang, Katia Schlienger, et al.Pageof 211